487 participants
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-14
- Start Date:
- 2023-06-15
- Completion:
- 2026-07-15
Conditions
- Rheumatoid Arthritis
Interventions
- DRUG
No Results Yet